maximizing Oncology exploration with built-in KRAS Assay expert services and RAS Assays
from the promptly evolving industry of oncology exploration, accurate and successful mutation screening is vital for acquiring specific therapies. The KRAS solutions Platform plays a pivotal function Within this landscape by presenting detailed methods for KRAS mutation profiling and analysis. KRAS mutations, found in around ninety five% of RAS-rel